Baxter International Inc. $BAX Shares Bought by Amundi

Key Points

• Amundi increased its Baxter International stake by 12.2% in the second quarter, acquiring 97,411 additional shares and bringing its holdings to 895,147 shares valued at approximately $19.1 million. Institutional investors and hedge funds collectively own 90.19% of the company.
• Analysts remain broadly neutral on Baxter, with a consensus “Hold” rating and an average price target of $22.45. Recent firms raised their price targets to between $24 and $28, while maintaining mostly Hold or Neutral ratings.
• Baxter exceeded quarterly expectations, reporting $0.56 in EPS versus the $0.37 consensus and revenue of $2.96 billion, up 5.3% year over year. The company also issued a quarterly dividend of $0.01 per share, equivalent to a 0.2% annualized yield.

Amundi grew its position in Baxter International Inc. (NYSE:BAX - Free Report) by 12.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 895,147 shares of the medical instruments supplier's stock after acquiring an additional 97,411 shares during the quarter. Amundi owned approximately 0.17% of Baxter International worth $19,085,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Baxter International during the 2nd quarter valued at approximately $964,000. CYBER HORNET ETFs LLC boosted its position in shares of Baxter International by 52.4% during the 2nd quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier's stock valued at $46,000 after purchasing an additional 740 shares in the last quarter. California State Teachers Retirement System grew its stake in shares of Baxter International by 2,009.1% in the 2nd quarter. California State Teachers Retirement System now owns 12,720,343 shares of the medical instruments supplier's stock worth $271,198,000 after purchasing an additional 12,117,222 shares during the last quarter. Wedmont Private Capital raised its holdings in shares of Baxter International by 74.8% in the 2nd quarter. Wedmont Private Capital now owns 49,891 shares of the medical instruments supplier's stock worth $1,129,000 after purchasing an additional 21,356 shares in the last quarter. Finally, PCG Wealth Advisors LLC acquired a new stake in Baxter International during the second quarter valued at approximately $212,000. 90.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

BAX has been the topic of several recent research reports. Stifel Nicolaus lifted their price target on shares of Baxter International from $19.00 to $24.00 and gave the stock a "hold" rating in a research report on Tuesday, July 28th. Citigroup raised Baxter International from a "sell" rating to a "neutral" rating and raised their price objective for the stock from $17.00 to $28.00 in a research note on Friday, July 31st. TD Cowen lifted their target price on Baxter International from $20.00 to $24.00 and gave the stock a "hold" rating in a report on Monday, July 27th. UBS Group boosted their target price on Baxter International from $19.00 to $25.00 and gave the stock a "hold" rating in a research report on Tuesday, July 28th. Finally, Weiss Ratings raised Baxter International from a "sell (d-)" rating to a "sell (d)" rating in a report on Friday, July 31st. Two analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, Baxter International currently has a consensus rating of "Hold" and an average price target of $22.45.

Baxter International Price Performance

Shares of NYSE:BAX opened at $23.80 on Friday. The company's fifty day moving average is $24.98 and its two-hundred day moving average is $20.84. The company has a market cap of $12.31 billion, a P/E ratio of -11.50, a price-to-earnings-growth ratio of 3.65 and a beta of 0.60. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 1.39.

Baxter International (NYSE:BAX - Get Free Report) last issued its earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, topping the consensus estimate of $0.37 by $0.19. The business had revenue of $2.96 billion during the quarter, compared to analysts' expectations of $2.80 billion. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%.Baxter International's revenue was up 5.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. Equities analysts expect that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.

Baxter International Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, August 28th will be given a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, August 28th. Baxter International's dividend payout ratio is -1.93%.

Baxter International Profile

Baxter International Inc is a global healthcare company that develops and supplies medical products and technologies used in hospitals, outpatient facilities, physician offices and other care settings. Its offerings include intravenous therapy products and infusion systems, injectable medications and drug-compounding technologies, surgical products, patient-monitoring systems, respiratory-care equipment, and products used in hospital beds and connected-care environments.

The company serves healthcare providers and patients in numerous countries, with operations and customers across North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.